Skip to main content
U.S. flag

An official website of the United States government

This site is currently in beta, and your feedback is helping shape its ongoing development.

Return to search results

Prescription Drugs Introduced to Market

Published by Department of Health Care Access and Information | State of California | Metadata Last Checked: February 26, 2026 | Last Modified: 2026-02-05T22:07:46.397770
This dataset provides data for new prescription drugs introduced to market in California with a Wholesale Acquisition Cost (WAC) that exceeds the Medicare Part D specialty drug cost threshold. Prescription drug manufacturers submit information to HCAI within a specified time period after a drug is introduced to market. Key data elements include the National Drug Code (NDC) administered by the FDA, a narrative description of marketing and pricing plans, and WAC, among other information. Manufacturers may withhold information that is not in the public domain. Note that prescription drug manufacturers are able to submit new drug reports for a prior quarter at any time. Therefore, the data set may include additional new drug report(s) from previous quarter(s). There are two types of New Drug data sets: Monthly and Annual. The Monthly data sets include the data in completed reports submitted by manufacturers for calendar year 2026, as of February 5, 2026. The Annual data sets include data in completed reports submitted by manufacturers for the specified year. The data sets may include reports that do not meet the specified minimum thresholds for reporting. The program regulations are available here: https://hcai.ca.gov/wp-content/uploads/2024/03/CTRx-Regulations-Text.pdf The data format and file specifications are available here: https://hcai.ca.gov/wp-content/uploads/2024/03/Format-and-File-Specifications-version-2.0-ada.pdf DATA NOTES: Due to recent changes in Excel capabilities, it is not recommended that you save these files to .csv format. If you do, when importing back into Excel the leading zeros in the NDC number column will be dropped. If you need to save it into a different format other than .xlsx it must be .txt Submitted reports that are still under review by HCAI are not included in these files. DATA UPDATES: Drug manufacturers may submit New Drug reports to HCAI for prescription drugs which were not initially reported when they were introduced to market. CTRx staff update the posted datasets monthly for current year data and as needed for previous years. Please check the 'Data last updated' date on each dataset page to ensure you are viewing the most current data.

Resources

11 resources available

  • Q1-Q4 2022 Prescription Drugs Introduced to Market

    XLSX
    Download

  • Q1-Q4 2023 Prescription Drugs Introduced to Market

    XLSX
    Download

  • Q1-Q4 2021 Prescription Drugs Introduced to Market

    XLSX
    Download

  • Q1-Q4 2020 Prescription Drugs Introduced to Market

    XLSX
    Download

  • Data Dictionary - Prescription Drugs Introduced to Market

    CSV
    Download

  • Q1-Q4 2019 Prescription Drugs Introduced to Market

    XLSX
    Download

  • Q1-Q4 2024 Prescription Drugs Introduced to Market

    XLSX
    Download

  • Data Dictionary - Q1-Q4 2019 Prescription Drugs Introduced to Market

    CSV
    Download

  • February 2026 Monthly Update - Prescription Drugs Introduced to Market (CSV)

    CSV
    Download

  • February 2026 Monthly Update - Prescription Drugs Introduced to Market (Excel)

    XLSX
    Download

  • All resource data

    ZIP
    Download

Find Related Datasets

Click any tag below to search for similar datasets

Complete Metadata
@type dcat:Dataset
accessLevel public
contactPoint 
                                            {
  "fn": "Cost Transparency Rx",
  "@type": "vcard:Contact",
  "hasEmail": "mailto:ctrx@hcai.ca.gov"
}
description This dataset provides data for new prescription drugs introduced to market in California with a Wholesale Acquisition Cost (WAC) that exceeds the Medicare Part D specialty drug cost threshold. Prescription drug manufacturers submit information to HCAI within a specified time period after a drug is introduced to market. Key data elements include the National Drug Code (NDC) administered by the FDA, a narrative description of marketing and pricing plans, and WAC, among other information. Manufacturers may withhold information that is not in the public domain. Note that prescription drug manufacturers are able to submit new drug reports for a prior quarter at any time. Therefore, the data set may include additional new drug report(s) from previous quarter(s). There are two types of New Drug data sets: Monthly and Annual. The Monthly data sets include the data in completed reports submitted by manufacturers for calendar year 2026, as of February 5, 2026. The Annual data sets include data in completed reports submitted by manufacturers for the specified year. The data sets may include reports that do not meet the specified minimum thresholds for reporting. The program regulations are available here: https://hcai.ca.gov/wp-content/uploads/2024/03/CTRx-Regulations-Text.pdf The data format and file specifications are available here: https://hcai.ca.gov/wp-content/uploads/2024/03/Format-and-File-Specifications-version-2.0-ada.pdf DATA NOTES: Due to recent changes in Excel capabilities, it is not recommended that you save these files to .csv format. If you do, when importing back into Excel the leading zeros in the NDC number column will be dropped. If you need to save it into a different format other than .xlsx it must be .txt Submitted reports that are still under review by HCAI are not included in these files. DATA UPDATES: Drug manufacturers may submit New Drug reports to HCAI for prescription drugs which were not initially reported when they were introduced to market. CTRx staff update the posted datasets monthly for current year data and as needed for previous years. Please check the 'Data last updated' date on each dataset page to ensure you are viewing the most current data.
distribution 
                                            [
  {
    "@type": "dcat:Distribution",
    "title": "Q1-Q4 2022 Prescription Drugs Introduced to Market",
    "format": "XLSX",
    "mediaType": "application/vnd.openxmlformats-officedocument.spreadsheetml.sheet",
    "describedBy": "https://data.ca.gov/api/action/datastore_search?resource_id=2dd3baed-bf97-4f6f-a795-7d1b6924d0a7&limit=0",
    "downloadURL": "https://data.chhs.ca.gov/dataset/e54d331c-65d3-4c6e-b4ba-390bd7024248/resource/11a91095-1597-4b6a-b0b3-09e76422ce40/download/q1-q4-2022-prescription-drugs-introduced-to-market.xlsx",
    "describedByType": "application/json"
  },
  {
    "@type": "dcat:Distribution",
    "title": "Q1-Q4 2023 Prescription Drugs Introduced to Market",
    "format": "XLSX",
    "mediaType": "application/vnd.openxmlformats-officedocument.spreadsheetml.sheet",
    "describedBy": "https://data.ca.gov/api/action/datastore_search?resource_id=359790f3-9050-41b4-ad28-6d661e6f442c&limit=0",
    "downloadURL": "https://data.chhs.ca.gov/dataset/e54d331c-65d3-4c6e-b4ba-390bd7024248/resource/f0899438-0fb5-42d5-87f5-621e2f0b1b51/download/q1-q4-2023-prescription-drugs-introduced-to-market.xlsx",
    "describedByType": "application/json"
  },
  {
    "@type": "dcat:Distribution",
    "title": "Q1-Q4 2021 Prescription Drugs Introduced to Market",
    "format": "XLSX",
    "mediaType": "application/vnd.openxmlformats-officedocument.spreadsheetml.sheet",
    "describedBy": "https://data.ca.gov/api/action/datastore_search?resource_id=5059c2d0-f238-4ea8-976d-c842a39d375a&limit=0",
    "downloadURL": "https://data.chhs.ca.gov/dataset/e54d331c-65d3-4c6e-b4ba-390bd7024248/resource/5a80b890-24bb-4d66-a0bb-d6c46a150065/download/q1-q4-2021-prescription-drugs-introduced-to-market.xlsx",
    "describedByType": "application/json"
  },
  {
    "@type": "dcat:Distribution",
    "title": "Q1-Q4 2020 Prescription Drugs Introduced to Market",
    "format": "XLSX",
    "mediaType": "application/vnd.openxmlformats-officedocument.spreadsheetml.sheet",
    "describedBy": "https://data.ca.gov/api/action/datastore_search?resource_id=5aa3661b-9180-4097-8907-1324cf91e784&limit=0",
    "downloadURL": "https://data.chhs.ca.gov/dataset/e54d331c-65d3-4c6e-b4ba-390bd7024248/resource/9a37709e-4151-4300-a031-91ea7813da60/download/q1-q4-2020-prescription-drugs-introduced-to-market.xlsx",
    "describedByType": "application/json"
  },
  {
    "@type": "dcat:Distribution",
    "title": "Data Dictionary - Prescription Drugs Introduced to Market",
    "format": "CSV",
    "mediaType": "text/csv",
    "describedBy": "https://data.ca.gov/api/action/datastore_search?resource_id=73d61ccb-5513-4007-adbf-1d1096df3fe0&limit=0",
    "downloadURL": "https://data.chhs.ca.gov/dataset/e54d331c-65d3-4c6e-b4ba-390bd7024248/resource/74c10fe7-1b66-4288-b870-9ea3db310b26/download/new-prescription-drug-data-dictionary.csv",
    "describedByType": "application/json"
  },
  {
    "@type": "dcat:Distribution",
    "title": "Q1-Q4 2019 Prescription Drugs Introduced to Market",
    "format": "XLSX",
    "mediaType": "application/vnd.openxmlformats-officedocument.spreadsheetml.sheet",
    "describedBy": "https://data.ca.gov/api/action/datastore_search?resource_id=8d135b25-ca52-4c10-835a-7e59307f6699&limit=0",
    "downloadURL": "https://data.chhs.ca.gov/dataset/e54d331c-65d3-4c6e-b4ba-390bd7024248/resource/6393cda0-6101-424e-b738-07aee9e6f94f/download/q1-q4-2019-prescription-drugs-introduced-to-market.xlsx",
    "describedByType": "application/json"
  },
  {
    "@type": "dcat:Distribution",
    "title": "Q1-Q4 2024 Prescription Drugs Introduced to Market",
    "format": "XLSX",
    "mediaType": "application/vnd.openxmlformats-officedocument.spreadsheetml.sheet",
    "describedBy": "https://data.ca.gov/api/action/datastore_search?resource_id=99c3356d-262e-4940-a33a-1a0ec5c259f4&limit=0",
    "downloadURL": "https://data.chhs.ca.gov/dataset/e54d331c-65d3-4c6e-b4ba-390bd7024248/resource/0e3afcfc-a5eb-41c6-a633-deaa2bfb5710/download/q1-q4-2024-prescription-drugs-introduced-to-market.xlsx",
    "describedByType": "application/json"
  },
  {
    "@type": "dcat:Distribution",
    "title": "Data Dictionary - Q1-Q4 2019 Prescription Drugs Introduced to Market",
    "format": "CSV",
    "mediaType": "text/csv",
    "description": "Data Dictionary for https://data.chhs.ca.gov/dataset/e54d331c-65d3-4c6e-b4ba-390bd7024248/resource/6393cda0-6101-424e-b738-07aee9e6f94f/download/q1-q4-2019-prescription-drugs-introduced-to-market.xlsx",
    "downloadURL": "https://data.ca.gov/datastore/dictionary_download/8d135b25-ca52-4c10-835a-7e59307f6699",
    "isDataDictionary": true
  },
  {
    "@type": "dcat:Distribution",
    "title": "February 2026 Monthly Update - Prescription Drugs Introduced to Market (CSV)",
    "format": "CSV",
    "mediaType": "text/csv",
    "downloadURL": "https://data.chhs.ca.gov/dataset/e54d331c-65d3-4c6e-b4ba-390bd7024248/resource/2be5663e-8862-42e8-bd0e-3476d8baf7c3/download/new-drug-data-jan-2026.csv"
  },
  {
    "@type": "dcat:Distribution",
    "title": "February 2026 Monthly Update - Prescription Drugs Introduced to Market (Excel)",
    "format": "XLSX",
    "mediaType": "application/vnd.openxmlformats-officedocument.spreadsheetml.sheet",
    "downloadURL": "https://data.chhs.ca.gov/dataset/e54d331c-65d3-4c6e-b4ba-390bd7024248/resource/4cf317a8-c7a4-40b7-8fa0-13fcad2ad0a2/download/new-drug-data-jan-2026.xlsx"
  },
  {
    "@type": "dcat:Distribution",
    "title": "All resource data",
    "format": "ZIP",
    "mediaType": "application/zip",
    "downloadURL": "https://data.chhs.ca.gov/dataset/e54d331c-65d3-4c6e-b4ba-390bd7024248/resource/82883221-f421-4b0f-90b6-616cee618e6a/download/prescription-drugs-introduced-to-market-g3blzum9.zip"
  }
]
identifier 8a017dbf-7a20-4899-889c-ca0b8283a767
issued 2019-03-05T16:45:32.819450
keyword 
                                            [
  "CTRx",
  "cost transparency",
  "department of health care access and information",
  "prescription drugs",
  "sb17"
]
license http://www.opendefinition.org/licenses/cc-by
modified 2026-02-05T22:07:46.397770
publisher 
                                            {
  "name": "Department of Health Care Access and Information",
  "@type": "org:Organization"
}
theme 
                                            [
  "Health and Human Services"
]
title Prescription Drugs Introduced to Market

data.gov

An official website of the GSA's Technology Transformation Services

Looking for U.S. government information and services?
Visit USA.gov